NYSE
9.35USD
-0.09 (-0.95%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
577.9M
P/E
—
EPS
—
Beta
0.88
52W range
7.77-32.76
Day range
9.24–9.66
Open
9.30
Prev close
9.44
Volume
1.2M
Avg volume
2M
Dividend
0.00
IPO
2019-07-18
https://www.prnewswire.com/news-releases/zts-investors-have-opportunity-to-lead-zoetis-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302799927.html · 6/15/2026-1.00
https://www.prnewswire.com/news-releases/veritone-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--veri-302799923.html · 6/15/2026-1.00
https://www.newsfilecorp.com/release/301321/PHR-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Phreesia-PHR-Investors-of-Securities-Class-Action-Lawsuit-Deadline-on-July-13-2026 · 6/14/2026-1.00
https://www.newsfilecorp.com/release/300537/SRAD-SHAREHOLDER-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-Sportradar-SRAD-Investors-of-Securities-Class-Action-Deadline-on-July-17-2026 · 6/9/2026-0.50
https://www.newsfilecorp.com/release/300335/PHR-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Phreesia-PHR-Investors-of-Securities-Class-Action-Deadline-on-July-13-2026 · 6/7/2026-1.00
https://www.newsfilecorp.com/release/300324/AVAV-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-AeroVironment-AVAV-Investors-of-Securities-Class-Action-Deadline-on-July-27-2026 · 6/7/2026-0.50
https://www.newsfilecorp.com/release/299283/NUAI-SHAREHOLDER-NOTICE-Faruqi-Faruqi-LLP-Reminds-New-Era-Energy-Digital-NUAI-Investors-of-Securities-Class-Action-Deadline-on-June-1-2026 · 5/28/2026-0.50
https://www.globenewswire.com/news-release/2026/05/27/3302431/32719/en/Robbins-LLP-Urges-PHR-Stockholders-Who-Lost-Money-Investing-in-Phreesia-Inc-to-Contact-the-Firm-for-Information-About-Leading-the-Class-Action.html · 5/27/2026-1.00
https://www.newsfilecorp.com/release/298448/PHR-UPCOMING-DEADLINE-Faruqi-Faruqi-LLP-Reminds-Phreesia-PHR-Investors-of-Securities-Class-Action-Deadline-on-July-13-2026 · 5/24/2026-1.00
https://www.newsfilecorp.com/release/298070/PHR-EQUITY-ACTION-REMINDER-Faruqi-Faruqi-LLP-Reminds-Phreesia-PHR-Investors-of-Securities-Class-Action-Deadline-on-July-13-2026 · 5/21/2026-1.00
https://www.newsfilecorp.com/release/297542/POET-DEADLINE-ALERT-Faruqi-Faruqi-LLP-Reminds-POET-Technologies-POET-Investors-of-Securities-Class-Action-Deadline-on-June-29-2026 · 5/17/2026-0.50
https://www.newsfilecorp.com/release/297544/PSIX-DEADLINE-ALERT-Faruqi-Faruqi-LLP-Reminds-Power-Solutions-International-PSIX-Investors-of-Securities-Class-Action-Deadline-on-May-19-2026 · 5/17/2026-0.50
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works